| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥284.9B | ¥263.0B | +8.3% |
| Operating Income | ¥4.3B | ¥7.6B | -43.8% |
| Ordinary Income | ¥7.8B | ¥8.7B | -9.3% |
| Net Income | ¥5.5B | ¥7.8B | -29.6% |
| ROE | 1.3% | 1.8% | - |
FY2025 Q3 cumulative results show revenue of 284.9B yen (YoY +8.3%), representing solid top-line growth, while profitability declined significantly with operating income of 4.3B yen (YoY -43.8%), ordinary income of 7.8B yen (YoY -9.3%), and net income of 5.5B yen (YoY -29.6%). The revenue expansion was offset by margin compression, with gross profit margin at 16.7% and operating margin declining to 1.5%. Non-operating income of 4.7B yen partially cushioned the operating profit decline, keeping ordinary income deterioration more moderate. The company maintains strong liquidity with cash and deposits of 13.7B yen, though long-term borrowings surged from 0.3B yen to 9.4B yen YoY, and construction in progress expanded to 7.2B yen, indicating substantial capital investments underway. Full-year guidance projects operating income of 0.7B yen and net income of 0.5B yen, implying significant improvement required in Q4.
[Profitability] ROE of 1.3% reflects substantial decline from prior levels, driven primarily by net profit margin compression to 1.9% and asset turnover of 0.47x. Operating margin of 1.5% declined from 2.9% YoY by 1.4pt, with gross margin at 16.7% indicating pricing or cost pressures. Financial leverage stands at 1.40x. The DuPont analysis reveals net profit margin deterioration as the primary driver of ROE weakness, with selling, general and administrative expenses rising faster than gross profit growth. [Cash Quality] Cash and deposits of 13.7B yen provide coverage of 20.3x against short-term borrowings of 0.5B yen and 2.0x against current liabilities of 6.8B yen. Working capital metrics show challenges with Days Sales Outstanding at 94 days, Days Inventory Outstanding at 94 days, and Cash Conversion Cycle of 161 days, all indicating operational inefficiency. [Investment Efficiency] Total asset turnover of 0.47x trails the industry median of 0.58x, reflecting asset base expansion outpacing revenue growth. Construction in progress of 7.2B yen and property, plant and equipment increasing 58.2% YoY to 20.6B yen signal major capital deployment pending return generation. [Financial Health] Equity ratio of 71.4% remains robust compared to industry median of 63.8%, with current ratio of 506% indicating exceptional short-term liquidity. Debt-to-equity ratio of 0.23x is conservative, though long-term borrowings increased 2962% YoY, shifting capital structure toward higher leverage.
Cash and deposits increased 1.4B yen YoY to 13.7B yen despite profitability challenges, suggesting cash preservation through operational adjustments or financing activities. The balance sheet reveals short-term borrowings declined 6.8B yen to 0.5B yen while long-term borrowings surged 9.1B yen to 9.4B yen, indicating debt restructuring from short-term to long-term facilities to finance capital investments. Construction in progress of 7.2B yen represents the primary investment deployment, with total property, plant and equipment rising 7.6B yen YoY. Working capital shows mixed signals with accounts receivable including electronically recorded monetary claims totaling 26.7B yen, contributing to extended DSO of 94 days. Inventory increased modestly by 0.2B yen but turnover remains slow at 94 days DIO. Accounts payable decreased 0.8B yen YoY, resulting in Days Payable Outstanding of 27 days and an overall Cash Conversion Cycle of 161 days, which constrains operational cash generation. The substantial cash balance of 13.7B yen provides a buffer covering 2.0x current liabilities, maintaining financial flexibility despite working capital inefficiencies. Interest coverage stands at approximately 10.3x based on interest expense of 0.04B yen, indicating adequate debt servicing capacity even with increased borrowings.
Ordinary income of 7.8B yen versus operating income of 4.3B yen reflects non-operating net contribution of approximately 3.5B yen, representing 44.6% of ordinary income and 1.2% of revenue. Non-operating income totaled 4.7B yen, comprising primarily financial income and other non-core gains, while non-operating expenses of 1.2B yen included interest expense of 0.04B yen. The significant reliance on non-operating income to sustain profitability raises concerns about core business earnings power. The effective tax rate of 16.7% appears low, with a tax burden coefficient of 0.831, suggesting favorable tax positions or deferred tax benefits. Operating profit margin compression from 2.9% to 1.5% YoY indicates structural challenges in core operations, with selling, general and administrative expenses rising to maintain growth momentum. The extended Cash Conversion Cycle of 161 days and slow inventory turnover suggest potential accruals buildup, though specific operating cash flow data is unavailable to confirm cash-backed earnings quality. Multiple quality alerts emerge from operational inefficiency metrics, capital deployment without corresponding margin expansion, and elevated accounts receivable suggesting potential revenue recognition timing issues or customer credit extensions.
Margin compression risk remains elevated as gross profit margin of 16.7% trails industry standards and operating leverage has turned negative with SG&A expenses growing faster than revenue. Without successful pricing actions, product mix optimization, or cost restructuring, profitability may continue deteriorating. Long-term borrowing increased 9.1B yen to 9.4B yen YoY while construction in progress reached 7.2B yen, creating investment payback risk if new facilities fail to generate planned returns or experience commissioning delays. The company must demonstrate clear ROI trajectories and project timelines to justify this capital deployment scale. Dividend sustainability concerns arise from the 118% payout ratio based on annualized Q3 results, with planned annual dividend of 54 yen against full-year net income guidance of 0.5B yen. If profitability remains weak, dividend coverage will strain cash resources despite current strong liquidity of 13.7B yen.
[Industry Position] (Reference - Proprietary Analysis) The company operates in the manufacturing sector where median profitability and efficiency metrics provide context for performance evaluation. Profitability: Operating margin of 1.5% significantly underperforms the industry median of 8.3% (IQR: 4.8-12.6%), ranking in the bottom quartile. Net profit margin of 1.9% also trails the industry median of 6.3% (IQR: 3.2-9.0%), indicating substantial margin disadvantage. ROE of 1.3% falls well below the industry median of 5.0% (IQR: 2.9-8.1%), reflecting weak return generation. Efficiency: Asset turnover of 0.47x lags the industry median of 0.58x (IQR: 0.42-0.66), suggesting below-average asset productivity. Days Sales Outstanding of 94 days compares reasonably to industry median of 83 days, while Days Inventory Outstanding of 94 days sits near the median of 109 days. However, Days Payable Outstanding of 27 days substantially trails the median of 56 days, contributing to an extended Cash Conversion Cycle of 161 days versus industry median of 108 days. Financial Health: Equity ratio of 71.4% exceeds the industry median of 63.8% (IQR: 49.5-74.7%), indicating conservative capitalization. Current ratio of 506% far surpasses the median of 2.84x (IQR: 2.10x-3.81x), demonstrating exceptional liquidity. Growth: Revenue growth of 8.3% YoY outpaces the industry median of 2.7% (IQR: -1.9% to 7.9%), placing the company in the upper quartile for top-line expansion despite profitability challenges. (Industry: Manufacturing, N=98 companies for most metrics, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Revenue growth momentum of 8.3% YoY demonstrates market traction and successful business expansion, positioning the company above industry median growth rates. However, this growth has not translated to bottom-line performance, with operating margin compression of 1.4pt YoY to 1.5% creating a critical profitability challenge that requires operational restructuring or pricing power demonstration. The substantial capital deployment program evidenced by 9.1B yen increase in long-term borrowings and 7.2B yen construction in progress represents a strategic inflection point. Success hinges on timely facility commissioning and achievement of projected returns to reverse margin deterioration and validate the 118% payout ratio, which currently appears unsustainable without meaningful earnings recovery. Working capital inefficiencies with 161-day Cash Conversion Cycle and particularly low Days Payable Outstanding of 27 days versus industry median of 56 days suggest immediate opportunities for cash flow optimization through supplier payment term negotiations and inventory management improvements. The company's strong balance sheet position with 71.4% equity ratio and exceptional liquidity provides financial runway to execute turnaround initiatives, though investors should monitor Q4 performance closely against full-year guidance requiring significant sequential improvement to achieve operating income of 0.7B yen and net income of 0.5B yen targets.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.